These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Pharmacokinetics of cimetidine in patients with liver disease. González-Martin G, Arancibia A, Fajuri M, Chesta J, Novoa X. Int J Clin Pharmacol Ther Toxicol; 1985 Jul; 23(7):355-8. PubMed ID: 4030163 [Abstract] [Full Text] [Related]
13. Pharmacokinetics of cimetidine and its sulphoxide metabolite during haemodialysis. Larsson R, Erlanson P, Bodemar G, Norlander B, Fransson L, Strouth L. Eur J Clin Pharmacol; 1982 Mar; 21(4):325-30. PubMed ID: 7056278 [Abstract] [Full Text] [Related]
14. Comparison of bioavailability and pharmacokinetics of cimetidine in subjects with normal and impaired renal function. Guay DR, Matzke GR, Bockbrader HN, Dancik J. Clin Pharm; 1983 Mar; 2(2):157-62. PubMed ID: 6883944 [Abstract] [Full Text] [Related]
15. The pharmacokinetics of H2 receptor blocking agents in compensated liver cirrhosis. Okolicsányi L, Venuti M, Strazzabosco M, Iemmolo RM, Nassuato G, Orlando R, Lirussi F. Acta Physiol Hung; 1984 Mar; 64(3-4):393-400. PubMed ID: 6099684 [Abstract] [Full Text] [Related]
16. Cimetidine kinetics and dynamics in patients with severe liver disease. Villeneuve JP, Fortunet-Fouin H, Arsène D. Hepatology; 1983 Mar; 3(6):923-7. PubMed ID: 6629322 [Abstract] [Full Text] [Related]